On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.
People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.
Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...
The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
It’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the ...
Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new sophistication. The management of chronic pain in general is now being broadly ...